Travis Lindsay
Investor @Nufund Venture Group
Signup · Get unlimited contacts
WORK HISTORY
Investor @Nufund Venture Group
San Diego, CA, US
NuFund Venture Group is a new wave of angel investors with a new fund model investing in new technology leaders. NuFund was formerly known as Tech Coast Angels – San Diego (TCA – SD), and the organization is one of the largest, most active and most successful early-stage investor groups over the past 20+ years. We continually strive to foster a culture that is friendly, innovative, engaging, rewarding and fun for all stakeholders.The group has over 350 active accredited investors from all walks of life. NuFund invested $15 million in 2021. The group is focused mainly on Tech and Life Science.
EDUCATION
Southern Methodist University - Cox School of Business
M.B.A.
San Diego State University-California State University
Bachelor of Arts (B.A.)
SKILLS
ABOUT TRAVIS LINDSAY
Over 20 years of executive leadership and management experience, with an extensive background in the medical device, biotechnology, and pharmaceutical industries. Throughout Travis\' career, he has built a solid portfolio of achievements that includes significant and steady revenue/profit growth, market share gains, and breakthrough turnaround initiatives.As a visionary senior leader and astute strategist for top-priority business goals, he has a proven record of positioning companies for expanded market and product opportunities. In particular, he has the ability to recognize a vision for the organization, structure the organization and develop plans to act on the vision and finally, to ensure organizational execution. Travis has achieved success leading high-growth initiatives for large organizations and turnarounds for smaller struggling organizations. His leadership style is decisive and plan driven. He is an excellent communicator and team builder who commands respect from all organizational levels. PERFORMANCE HIGHLIGHTS Drove Carl Zeiss Meditec to #1 brand position for medical technology in eye care Led Heidelberg Engineering to 30% YOY sales increase for 6 consecutive years Spearheaded full loss-to-profit reversal for Respironics/Lifecare European operations, generating 50% of corporate profits on 20% global sales Facilitated 16% growth for Luneau Technology with projected 150% gains
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.